Patents Assigned to LETAVIS AB
  • Patent number: 12402621
    Abstract: Disclosed is a method for increasing the bud opening and/or longevity of cut flowers by exposing the cut flowers to an oxytocin solution and/or a variant and/or derivative thereof.
    Type: Grant
    Filed: December 18, 2020
    Date of Patent: September 2, 2025
    Assignee: LETAVIS AB
    Inventors: Kerstin Uvnäs-Moberg, Bengt Lundegårdh
  • Patent number: 12376530
    Abstract: Described is a method for vegetative propagation of plants by exposing a plant material to an oxytocin solution and/or a variant and/or derivative thereof.
    Type: Grant
    Filed: June 15, 2021
    Date of Patent: August 5, 2025
    Assignee: LETAVIS AB
    Inventors: Kerstin Uvnäs-Moberg, Bengt Lundegårdh
  • Patent number: 11560358
    Abstract: The present document is directed to co-crystals of resveratrol and/or curcumin with piperazine and their use in medicine and/or as food and feed supplements.
    Type: Grant
    Filed: April 9, 2019
    Date of Patent: January 24, 2023
    Assignee: LETAVIS AB
    Inventors: Mihaela Maria Pop, Paula Vasilichia Bulieris, Ingemar Pongratz, Victor Fruth-Oprisan, Raul-Augustin Mitran